1. Home
  2. FPI vs CADL Comparison

FPI vs CADL Comparison

Compare FPI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.74

Market Cap

503.5M

Sector

Real Estate

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.05

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
CADL
Founded
2013
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
578.8M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FPI
CADL
Price
$9.74
$8.05
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
338.2K
1.8M
Earning Date
04-29-2026
05-14-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
58.62
EPS
0.01
N/A
Revenue
$52,178,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$976.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$4.35
52 Week High
$13.23
$9.57

Technical Indicators

Market Signals
Indicator
FPI
CADL
Relative Strength Index (RSI) 32.58 48.87
Support Level $9.44 $4.80
Resistance Level $10.59 $9.42
Average True Range (ATR) 0.22 0.59
MACD -0.03 -0.11
Stochastic Oscillator 8.65 3.77

Price Performance

Historical Comparison
FPI
CADL

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: